(Q46004595)

18 December 2017

title

Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia. (English)

1 reference

18 December 2017

0 references

0 references

0 references

4

1 reference

18 December 2017

author name string

Yong Kee Choi

1

1 reference

18 December 2017

Shikha Snigdha

2

1 reference

18 December 2017

Mohammed Shahid

3

1 reference

18 December 2017

Frank I Tarazi

5

1 reference

18 December 2017

publication date

20 May 2009

1 reference

18 December 2017

Journal of Molecular Neuroscience

published in

1 reference

18 December 2017

volume

38

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

227-235

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s12031-009-9204-9

exact match

0 references

cites work

Recent advances in the phencyclidine model of schizophrenia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-009-9204-9

Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-009-9204-9

The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-009-9204-9

Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.

21 January 2018

1 reference

12 December 2020

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

12 December 2020

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

1 reference

12 December 2020

Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

12 December 2020

The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys.

1 reference

12 December 2020

Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine.

1 reference

12 December 2020

Molecular targets for treating cognitive dysfunction in schizophrenia.

1 reference

12 December 2020

Predicting drug efficacy for cognitive deficits in schizophrenia

1 reference

12 December 2020

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

1 reference

12 December 2020

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

12 December 2020

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

1 reference

12 December 2020

Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys

1 reference

12 December 2020

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

1 reference

12 December 2020

5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin

1 reference

12 December 2020

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

12 December 2020

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

1 reference

12 December 2020

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

1 reference

12 December 2020

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions

1 reference

12 December 2020

Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors

1 reference

12 December 2020

Glutamatergic mechanisms in schizophrenia

1 reference

12 December 2020

Working memory deficit as a core neuropsychological dysfunction in schizophrenia

1 reference

12 December 2020

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

1 reference

12 December 2020

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

1 reference

12 December 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

12 December 2020

Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs.

1 reference

12 December 2020

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

12 December 2020

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex.

1 reference

12 December 2020

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment

1 reference

12 December 2020

Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.

1 reference

12 December 2020

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

12 December 2020

Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation

1 reference

12 December 2020

PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site

1 reference

12 December 2020

Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.

1 reference

12 December 2020

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

1 reference

12 December 2020

Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.

1 reference

12 December 2020

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

1 reference

12 December 2020

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

1 reference

12 December 2020

Simultaneous modulation of retrieval by dopaminergic D(1), beta-noradrenergic, serotonergic-1A and cholinergic muscarinic receptors in cortical structures of the rat.

1 reference

12 December 2020

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

12 December 2020

Asenapine induces differential regional effects on serotonin receptor subtypes

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.

1 reference

12 December 2020

Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats

1 reference

12 December 2020

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

12 December 2020

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

1 reference

12 December 2020

10.1007/S12031-009-9204-9

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017